ENSC
Price
$2.48
Change
-$0.00 (-0.00%)
Updated
Oct 15, 11:15 AM (EDT)
Capitalization
7.36M
Intraday Buy/Sell Signals
RZLT
Price
$8.64
Change
+$0.22 (+2.61%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
763.86M
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ENSC vs RZLT

Header iconENSC vs RZLT Comparison
Open Charts ENSC vs RZLTBanner chart's image
Ensysce Biosciences
Price$2.48
Change-$0.00 (-0.00%)
Volume$149
Capitalization7.36M
Rezolute
Price$8.64
Change+$0.22 (+2.61%)
Volume$13.61K
Capitalization763.86M
ENSC vs RZLT Comparison Chart in %
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. RZLT commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and RZLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (ENSC: $2.48 vs. RZLT: $8.41)
Brand notoriety: ENSC and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 72% vs. RZLT: 101%
Market capitalization -- ENSC: $7.36M vs. RZLT: $763.86M
ENSC [@Biotechnology] is valued at $7.36M. RZLT’s [@Biotechnology] market capitalization is $763.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENSC and RZLT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 6 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • ENSC’s TA Score: 6 bullish, 4 bearish.
  • RZLT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than RZLT.

Price Growth

ENSC (@Biotechnology) experienced а +2.48% price change this week, while RZLT (@Biotechnology) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

RZLT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($764M) has a higher market cap than ENSC($7.36M). RZLT YTD gains are higher at: 71.633 vs. ENSC (-69.533). ENSC has higher annual earnings (EBITDA): -6.56M vs. RZLT (-77.12M). RZLT has more cash in the bank: 86.9M vs. ENSC (2.21M). ENSC has less debt than RZLT: ENSC (425K) vs RZLT (1.78M). ENSC (0) and RZLT (0) have equivalent revenues.
ENSCRZLTENSC / RZLT
Capitalization7.36M764M1%
EBITDA-6.56M-77.12M9%
Gain YTD-69.53371.633-97%
P/E Ratio0.02N/A-
Revenue00-
Total Cash2.21M86.9M3%
Total Debt425K1.78M24%
FUNDAMENTALS RATINGS
ENSC vs RZLT: Fundamental Ratings
ENSC
RZLT
OUTLOOK RATING
1..100
2266
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4837
P/E GROWTH RATING
1..100
75100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (21) in the null industry is in the same range as RZLT (35). This means that ENSC’s stock grew similarly to RZLT’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as RZLT (100). This means that ENSC’s stock grew similarly to RZLT’s over the last 12 months.

RZLT's SMR Rating (99) in the null industry is in the same range as ENSC (100). This means that RZLT’s stock grew similarly to ENSC’s over the last 12 months.

RZLT's Price Growth Rating (37) in the null industry is in the same range as ENSC (48). This means that RZLT’s stock grew similarly to ENSC’s over the last 12 months.

ENSC's P/E Growth Rating (75) in the null industry is in the same range as RZLT (100). This means that ENSC’s stock grew similarly to RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCRZLT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 16 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOSBX29.700.45
+1.54%
Tributary Small Company Instl Plus
FESRX11.480.15
+1.32%
First Eagle Small Cap Opportunity R6
DPLGX29.95N/A
N/A
Jackson Square Large-Cap Growth IS
RYLSX89.79N/A
N/A
Rydex Leisure A
AEIUX8.95N/A
N/A
American Century Equity Income R5

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
+6.90%
MLLCF - ENSC
37%
Loosely correlated
N/A
HNSBF - ENSC
33%
Loosely correlated
N/A
SYRE - ENSC
31%
Poorly correlated
+11.02%
NEUP - ENSC
31%
Poorly correlated
-4.67%
SNSE - ENSC
31%
Poorly correlated
+8.03%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with AVBP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+4.21%
AVBP - RZLT
44%
Loosely correlated
-4.71%
DYN - RZLT
43%
Loosely correlated
+10.26%
SYRE - RZLT
43%
Loosely correlated
+11.02%
TERN - RZLT
43%
Loosely correlated
-1.40%
CRNX - RZLT
43%
Loosely correlated
-0.86%
More